Association between triglyceride/high-density lipoprotein ratio and hearing impairment in a Korean population

References

• World Health Organization. Deafness and hearing loss. Geneve: World Health Organization; 2017. [cited 2017 Feb 21]. Available from: http://www.who.int/pbd/deafness/estimates/en/
   Google Scholar
• Bainbridge KE, Wallhagen MI. Hearing loss in an aging American population: extent, impact, and management. Annu Rev Public Health. 2014;35:139–152.
   PubMed Web of Science ®Google Scholar
• Oron Y, Elgart K, Marom T, et al. Cardiovascular risk factors as causes for hearing impairment. Audiol Neurootol. 2014;19:256–260.
   PubMed Web of Science ®Google Scholar
• Kang SH, da Jung J, Lee KY, et al. Comparison of various anthropometric indices as risk factors for hearing impairment in Asian women. PLoS One. 2015;10:e0143119.
   PubMed Web of Science ®Google Scholar
• Lavinsky J, Wolff ML, Trasel AR, et al. Effect of hyperinsulinism on sensorineural hearing impairment in Ménière’s disease: a cohort study. Otol Neurotol. 2014;35:155–161.
   PubMed Web of Science ®Google Scholar
• Hadaegh F, Khalili D, Ghasemi A, et al. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis. 2009;19:401–408.
   PubMed Web of Science ®Google Scholar
• Salazar MR, Carbajal HA, Espeche WG, et al. Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals. Nutr Metab Cardiovasc Dis. 2017;27:366–373.
   PubMed Web of Science ®Google Scholar
• Kim J-S, Kang H-T, Shim J-Y, et al. The association between the triglyceride to high-density lipoprotein cholesterol ratio with insulin resistance (HOMA-IR) in the general Korean population: based on the National Health and Nutrition Examination Survey in 2007–2009. Diabetes Res Clin Pract. 2012;97:132–138.
   PubMed Web of Science ®Google Scholar
• He J, He S, Liu K, et al. The TG/HDL-C ratio might be a surrogate for insulin resistance in Chinese nonobese women. Int J Endocrinol. 2014;2014:1–7.
   Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752.
   PubMed Web of Science ®Google Scholar
• Rizzo M, Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. QJM. 2006;99:1–14.
   PubMed Web of Science ®Google Scholar
• Boizel R, Benhamou PY, Lardy B, et al. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care. 2000;23:1679–1685.
   PubMed Web of Science ®Google Scholar
• Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb. 2003;10:186–191.
   PubMedGoogle Scholar
• St-Pierre AC, Cantin B, Dagenais GR, et al. The triglyceride/high-density lipoprotein cholesterol ratio, the small dense low-density lipoprotein phenotype, and ischemic heart disease risk. Metab Synd Relat Disord. 2004;2:57–64.
   PubMed Web of Science ®Google Scholar
• Sonmez A, Yilmaz MI, Saglam M, et al. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease. Lipids Health Dis. 2015;14:29.
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399–404.
   PubMed Web of Science ®Google Scholar
• Costa OA. Inner ear pathology in experimental diabetes. Laryngoscope. 1967;77:68–75.
   PubMed Web of Science ®Google Scholar
• Fisch U, Dobozi M, Greig D. Degenerative changes of the arterial vessels of the internal auditory meatus during the process of aging. A histological study. Acta Otolaryngol. 1972;73:259–266.
   PubMed Web of Science ®Google Scholar
• Rosenhall U, Rubin W. Degenerative changes in the human vestibular sensory epithelia. Acta Otolaryngol. 1975;79:67–80.
   PubMed Web of Science ®Google Scholar
• Fukushima H, Cureoglu S, Schachern PA, et al. Effects of type 2 diabetes mellitus on cochlear structure in humans. Arch Otolaryngol Head Neck. 2006;132:934–938.
   PubMedGoogle Scholar
• Suzuki K, Kaneko M, Murai K. Influence of serum lipids on auditory function. Laryngoscope. 2000;110:1736–1738.
   PubMed Web of Science ®Google Scholar
• Chang N-C, Yu M-L, Ho K-Y, et al. Hyperlipidemia in noise-induced hearing loss. Otolaryngol Head Neck Surg. 2007;137:603–606.
   PubMed Web of Science ®Google Scholar
• Weng T, Devine EE, Xu H, et al. A clinical study of serum lipid disturbance in Chinese patients with sudden deafness. Lipid Health Dis. 2013;12:95.
   PubMed Web of Science ®Google Scholar
• Shargorodsky J, Curhan SG, Eavey R, et al. A prospective study of cardiovascular risk factors and incident hearing loss in men. Laryngoscope. 2010;120:1887–1891.
   PubMed Web of Science ®Google Scholar
• Simpson AN, Matthews LJ, Dubno JR. Lipid and C-reactive protein levels as risk factors for hearing loss in older adults. Otolaryngol Head Neck Surg. 2013;148:664–670.
   PubMed Web of Science ®Google Scholar
• Cai Q, Du X, Zhou B, et al. Effects of simvastatin on plasma lipoproteins and hearing loss in apolipoprotein E gene-deficient mice. ORL J Otolaryngol Relat Spec. 2009;71:244–250.
   PubMed Web of Science ®Google Scholar
• Lee MH, Kim HC, Ahn SV, et al. Prevalence of dyslipidemia among Korean adults: Korean National Health and Nutrition Survey 1998–2005. Diabetes Metab J. 2012;36:43–55.
   PubMedGoogle Scholar
• Weissglas-Volkov D, Pajukanta P. Genetic causes of high and low serum HDL-cholesterol. J Lipid Res. 2010;51:2032–2057.
   PubMed Web of Science ®Google Scholar